PAPER Goulburn AL, Alden D, Davis RP, Micallef SJ, Ng ES, Yu QC, Lim SM, Soh CL, Elliott DA, Hatzistavrou T, Bourke J, Watmuff B, Lang RJ, Haynes JM, Pouton CW, Giudice A, Trounson AO, Anderson SA, Stanley EG, Elefanty AG
SEARCH RESULTS
331009 RESULTS
PAPER Kanellopoulos D, Gunning FM, Morimoto SS, Hoptman MJ, Murphy CF, Kelly RE, Glatt C, Lim KO, Alexopoulos GS
Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.
Am J Geriatr Psychiatry. 2011 Jan;19(1):13-22. PubMed: 21218562PAPER Sachs-Erisson N, Sawyer K, Corsentino E, Collins N, Steffens DC
The moderating effect of the APOE [small element of] 4 allele on the relationship between hippocampal volume and cognitive decline in older depressed patients.
Am J Geriatr Psychiatry. 2011 Jan;19(1):23-32. PubMed: 21218563PAPER Ding S, Shi J, Qian W, Iqbal K, Grundke-Iqbal I, Gong CX, Liu F
Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A.
Neurobiol Aging. 2011 Jan 5; PubMed: 21215488PAPER Corrigan F, Pham CL, Vink R, Blumbergs PC, Masters CL, van den Heuvel C, Cappai R
The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains.
Brain Res. 2011 Mar 10;1378:137-43. PubMed: 21215734PAPER Jain S, Udgaonkar JB
Defining the pathway of worm-like amyloid fibril formation by the mouse prion protein by delineation of the productive and unproductive oligomerization reactions.
Biochemistry. 2011 Feb 22;50(7):1153-61. PubMed: 21214263PAPER Ahmad E, Ahmad A, Singh S, Arshad M, Khan AH, Khan RH
A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes.
Biochimie. 2011 May;93(5):793-805. PubMed: 21215287PAPER Olzscha H, Schermann SM, Woerner AC, Pinkert S, Hecht MH, Tartaglia GG, Vendruscolo M, Hayer-Hartl M, Hartl FU, Vabulas RM
Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions.
Cell. 2011 Jan 7;144(1):67-78. PubMed: 21215370PAPER Del Carmen Alonso A
Tau, neurodegeneration and Alzheimer's disease.
Curr Alzheimer Res. 2010 Dec;7(8):653-5. PubMed: 21214513PAPER Herrera JL, Diaz M, Hernández-Fernaud JR, Salido E, Alonso R, Fernández C, Morales A, Marin R
Voltage-dependent anion channel as a resident protein of lipid rafts: post-transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer's disease.
J Neurochem. 2011 Mar;116(5):820-7. PubMed: 21214547PAPER Yanagisawa K
Pathological significance of ganglioside clusters in Alzheimer's disease.
J Neurochem. 2011 Mar;116(5):806-12. PubMed: 21214549PAPER Lee JC, Simonyi A, Sun AY, Sun GY
Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.
J Neurochem. 2011 Mar;116(5):813-9. PubMed: 21214562PAPER Sodero AO, Trovò L, Iannilli F, Van Veldhoven P, Dotti CG, Martin MG
Regulation of tyrosine kinase B activity by the Cyp46/cholesterol loss pathway in mature hippocampal neurons: relevance for neuronal survival under stress and in aging.
J Neurochem. 2011 Mar;116(5):747-55. PubMed: 21214568PAPER Hicks D, John D, Makova NZ, Henderson Z, Nalivaeva NN, Turner AJ
Membrane targeting, shedding and protein interactions of brain acetylcholinesterase.
J Neurochem. 2011 Mar;116(5):742-6. PubMed: 21214569PAPER Grimm MO, Kuchenbecker J, Rothhaar TL, Grösgen S, Hundsdörfer B, Burg VK, Friess P, Müller U, Grimm HS, Riemenschneider M, Hartmann T
Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
J Neurochem. 2011 Mar;116(5):916-25. PubMed: 21214572Current Filters
No filters selected